Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9274407
rs9274407
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. 21570397

2011

dbSNP: rs9274407
rs9274407
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. 21570397

2011

dbSNP: rs6582630
rs6582630
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs6582630
rs6582630
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs3129900
rs3129900
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. 20639878

2010

dbSNP: rs3129900
rs3129900
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. 20639878

2010

dbSNP: rs2523822
rs2523822
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. 21570397

2011

dbSNP: rs2523822
rs2523822
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. 21570397

2011

dbSNP: rs2395029
rs2395029
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles. 30661239

2019

dbSNP: rs2395029
rs2395029
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs2395029
rs2395029
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs1497546
rs1497546
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs1497546
rs1497546
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs10937275
rs10937275
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs10937275
rs10937275
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs10812428
rs10812428
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASDB HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs10812428
rs10812428
Chemical and Drug Induced Liver Injury
0.800 GeneticVariation GWASCAT HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. 19483685

2009

dbSNP: rs7828135
rs7828135
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01. 25987243

2016

dbSNP: rs73122578
rs73122578
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017

dbSNP: rs72696020
rs72696020
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017

dbSNP: rs72631567
rs72631567
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017

dbSNP: rs6694270
rs6694270
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017

dbSNP: rs61858823
rs61858823
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017

dbSNP: rs6139258
rs6139258
Chemical and Drug Induced Liver Injury
C 0.700 GeneticVariation GWASCAT Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. 28062682

2017

dbSNP: rs597480
rs597480
Chemical and Drug Induced Liver Injury
0.700 GeneticVariation GWASCAT Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. 28043905

2017